ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752505; 2) Community: the network communities that were significantly associated with the response to NSC 752505; 3) Molecule: the relationships between components within communities and NSC 752505; 4) MDR: the compounds that were significantly associated with the NSC 752505.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.08155469
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0392716453377535 -0.091672848
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.1592166
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0392716453377535 0.2011438
NSC 734287 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0392716453377535 0.18686851
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0392716453377535 0.077030868
NSC 752346 Null 0.0392716453377535 0.037209894
NSC 755442 Null 0.0392716453377535 0.18334054
NSC 756401 GW832467X 0.0392716453377535 0.075848468
NSC 743694 Null 0.0392716453377541 -0.13933828
Total:28  Current:21    [First] [Prev] [Next] [Last]